Novo Nordisk launches Wegovy in India, expanding GLP-1 obesity drug market. The product competes with Eli Lilly's Mounjaro ...

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...

India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's ...

Deepseek AI’s scare kicked off the year, rattling faith in the “Magnificent Seven” and the broader tech space. 💵💰Don't miss ...

Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you ...

THEY are arguably the biggest medical breakthrough of recent times. And from this week, so-called ‘fat jabs’ will be made ...

GPs fear a wave of complaints from patients hoping to access the weight-loss drug tirzepatide in primary care - amid warnings ...

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to ...

It’s a shot at better health that comes with a promise to help shed the pounds. Demand for drugs like Ozempic, Wegovy, Mounjaro and Zepbound continues to grow. FILE – Donna ...